Blood Flow Restriction Training After Patellar INStability
Launched by CAITLIN CONLEY · Sep 16, 2020
Trial Information
Current as of April 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of physical therapy called blood flow restriction training (BFRT) to see if it helps people recover better from knee injuries, specifically those related to patellar instability, which can cause the kneecap to dislocate. The goal is to find out if this therapy can improve recovery and help individuals return to their usual activities more effectively.
To join the study, participants need to be between the ages of 14 and 40 and have been diagnosed with a knee injury related to patellar instability. They should be active and want to return to their pre-injury level of activity, like playing sports. Certain health conditions, such as diabetes or a history of blood clots, may prevent someone from participating. Those who qualify will take part in physical therapy sessions that focus on this new training method. This study is currently recruiting participants, so it's a great opportunity for those who meet the criteria and are looking to improve their knee health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of traumatic patellar instability (either primary or recurrent) determined by an American Board of Family Medicine certified physician with a Certificate of Added Qualifications in Sports Medicine or licensed Physical Therapist utilizing clinical examination, radiographic imaging, and patients' reports of instability
- • Age 14 to 40 years
- • Skeletally mature with closed growth plates visualized by radiograph
- • A score of 80 or more on the Sports Activity Scale, which corresponds to participating in "running, twisting, turning (tennis, racquetball, handball, ice hockey, field hockey, skiing, wrestling)" at least 1-3 times per week
- • Desire to resume pre-injury activity level
- Exclusion Criteria:
- • Concomitant osteochondral lesion requiring surgical fixation
- • Radiographic evidence of osteoarthritis (\< Kellgren-Lawrence Grade 2)
- • Previous ipsilateral or contralateral knee surgery
- • Most recent instability event more than 3 months before enrollment
- • History of any inflammatory disorder
- • BMI \> 35 kg/m2
- • Diabetes or uncontrolled hypertension
- • Varicose veins or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis
- • Pre-existing conditions or previous surgeries that effect the ability to walk
- • Planned trips or vacations that will result in the inability to attend 4 consecutive physical therapy sessions
About Caitlin Conley
Caitlin Conley is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous study design, Caitlin Conley collaborates with leading researchers and healthcare professionals to ensure the highest standards of clinical trial conduct. The organization emphasizes ethical practices, patient safety, and transparency throughout the research process, fostering an environment of trust and collaboration. Through strategic partnerships and a patient-centered approach, Caitlin Conley aims to contribute significantly to the development of new treatments and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Foxboro, Massachusetts, United States
Foxboro, Massachusetts, United States
Patients applied
Trial Officials
Caitlin Conley, PhD
Study Director
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials